2. February 2012

BioTech Start up Lipocalyx – ChiroBlock have finished an other important milestone

Only half a year after the foundation of the biotech company Lipocalyx, an important milestone of the demanding business plan could be reached successfully: The first proof of a new and promising drug delivery approach was delivered.

ChiroBlock, which took a strategical share in Lipocalyx, supports the company in providing sophisticated, new compounds which are part of Lipocalyx’ transfection system. After having passed this first critical milestone, both companies are confident to further make substantial progress within the next few months – resulting in a market entry of the new products by the year 2014.

Press Release 2011 – Collaboration Lipocalyx – ChiroBlock (german) (54 KB)

contact us

Cookie Setting: We use Cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our coporate commercial objectives, as well as other cookies which are used soley for anonymous statistical purposes, for more comfortable website settings, or for the display of personal content. You are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. You can always opt-out of our cookie settings. Further information can be found in our data policy.